¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"risk factor"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
risk benefit ratio
À§ÇèÆíÀͺñ
risk difference
À§ÇèµµÂ÷ÀÌ
risk management
À§Çèµµ°ü¸®
risk marker
À§ÇèÇ¥ÁöÀÚ
risk ratio
À§Çèºñ
antihemophilic factor
Ç×Ç÷¿ìº´ÀÎÀÚ
antineuritic factor
Ç׽Ű濰ÀÎÀÚ
antipellagra factor
Çׯç¶ó±×¶óÀÎÀÚ
antiphagocytic factor
Çׯ÷½ÄÀÎÀÚ, Ç׎½ÄÀÎÀÚ
antiplatelet factor
Ç×Ç÷¼ÒÆÇÀÎÀÚ
antirachitic factor
Ç×±¸·çº´ÀÎÀÚ
antiscorbutic factor
Ç×±«Ç÷º´ÀÎÀÚ
antisterility factor
Ç׺ÒÀÓÀÎÀÚ
atrial natriuretic factor
½É¹æ³ªÆ®·ýÀÌ´¢ÀÎÀÚ, ½É¹æ¼ÒµãÀÌ´¢ÀÎÀÚ
activation factor
Ȱ¼ºÀÎÀÚ
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
10
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
platelet-derived growth factor
Ç÷¼ÒÆÇÀ¯·¡¼ºÀåÀÎÀÚ, Ç÷¼ÒÆÇ±â¿ø¼ºÀåÀÎÀÚ
precipitation factor
ÃËÁø¿äÀÎ
predisposing factor
¼±Çà¿äÀÎ
prognostic factor
¿¹ÈÄÀÎÀÚ
psychological factor
½É¸®¿ä¼Ò
relaxing factor
ÀÌ¿ÏÀÎÀÚ
resistance factor
³»¼ºÀÎÀÚ, °ßµõÀÎÀÚ
rheumatoid factor
·ù¸¶Æ¼½ºÀÎÀÚ
transforming growth factor
Àüȯ¼ºÀåÀÎÀÚ
vascular endothelial growth factor
Ç÷°ü³»ÇǼºÀåÀÎÀÚ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
multiple risk
´ÙÁßÀ§Çèµµ
risk management
À§Çèµµ°ü¸®
risk marker
À§Ç赵ǥÁö
time dependent relative risk model
½Ã°£ÀÇÁ¸»ó´ëÀ§Çè¸ðµ¨
operative risk
¼ö¼úÀ§Çèµµ
physical hazard risk
¹°¸®ÀûÀ¯ÇØÀ§Çèµµ
population attributable risk
ÀϹÝÀα¸±â¿©À§Çèµµ
risk
À§Çè, À§Çèµµ
radiation risk
¹æ»ç¼±À§Çèµµ
recurrence risk
Àç¹ßÀ§Çèµµ
relative risk
ºñ±³À§Çèµµ
risk ratio
À§Çèµµºñ
risk benefit ratio
À§ÇèÆíÀͺñ
surgical risk
¼ö¼úÀ§Çèµµ
absorbed dose conversion factor
Èí¼ö¼±·®º¯È¯°è¼ö
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
AHF=£¾antihemophilic factor
Ç×Ç÷¿ìÀÎÀÚ.
B cell differentiation factor (BCDF)
B¼¼Æ÷ ºÐÈÀ¯¹ßÀÎÀÚ
B cell growth factor
B ¼¼Æ÷¼ºÀåÀÎÀÚ
B cell growth factor (BCGF)
B¼¼Æ÷ Áõ½ÄÃËÁøÀÎÀÚ
B cell stimulating factor (BSF)
B¼¼Æ÷ ÀÚ±ØÀÎÀÚ
Castles extrinsic factor
Ĺ½½¿ÜÀÎÀÚ.
Castles intrinsic factor
Ĺ½½³»ÀÎÀÚ.
Christmas factor
Å©¸®½º¸¶½º ÀÎÀÚ(ì×í)
Christmas factor.
Å©¸®½º¸¶½ºÀÎÀÚ
D factor
DÀÎÀÚ
Decay accelerating factor
ºØ±«°¡¼Ó¿ä¼Ò(¿äÀÎ)
EDCF (endothlium-derived contracting factor)
³»ÇǼ¼Æ÷¼º(Ò®ù«á¬øààõ) ¼öÃàÀÎÀÚ(â¥õêì×í)
EDRF (endothlium-derived relaxing factor)
³»ÇǼ¼Æ÷¼º(Ò®ù«á¬øààõ) ÀÌ¿ÏÀÎÀÚ(ì¬èÐì×í)
EDRF=£¾endothelium derived relaxing factor
³»ÇǼ¼Æ÷¼ºÀÌ¿ÏÀÎÀÚ.
F factor
FÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
radiation risk coeffecient
¹æ»ç¼±À§ÇèÁö¼ö
recurrence risk
Àç¹ßÀ§Çè
relative risk
ºñ±³À§Çèµµ
relative risk
ºñ±³À§Çèµµ(ËÓË´Ëô̴̬).
relative risk estimation
»ó´ë(-Àû) À§Çèµµ ÃßÁ¤(õÏïÒ)
risk management
À§Çè°ü¸®.
risk-benefit analysis
À§Çè-À̵æºÐ¼®
surgical risk
¼ö¼úÀ§Çèµµ(¼ö¼úÀ§ÇèŹ).
time dependent relative risk model
½Ã°£ÀÇÁ¸¼º »ó´ëÀ§Çè¸ðµ¨
col factor(»ýÈ) cÀÌ ÀÎÀÚ colicin factor
Äݸ®½ÅÀÎÀÚ.
lupus erythematosus factor = LE factor
È«¹Ý¼º ·çǪ½ºÀÎÀÚ(ûõÚèàõ¡ì×í)
time, dose and fractionation factor, TDF factor
½Ã°£¼±·®ºÐÇÒÀÎÀÚ
absorbed dose conversion factor
Èí¼ö¼±·®º¯È¯°è¼ö
age factor
¿¬·ÉÀÎÀÚ.
air kerma calibration factor
°ø±âÄ¿¸¶ÃøÁ¤°è¼ö, -´«±Ý¸ÂÃã°è¼ö
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½